Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20472746 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
Condition: Age-Related Macular Degeneration (AMD)
Intervention: Drug: pegaptanib sodium (Macugen)

Indicates status has not been verified in more than two years